Artiva Biotherapeutics, Inc. (ARTV) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -20.95M | -14.73M | -19.2M | -22.98M | -19.84M | -14.65M | -11.61M | -13.69M | -15.09M | -10.68M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | -6010.36% | -454.26% |
| Operating CF Growth % | -5.59% | -0.52% | -65.37% | -67.94% | -31.52% | -37.24% | - | - | - | - |
| Net Income | -23.52M | -20.77M | -21.53M | -21.25M | -20.31M | -16.09M | -17.47M | -17.84M | -13.96M | -12M |
| Depreciation & Amortization | 666K | 1.1M | 305K | 641K | 628K | 614K | 627K | 603K | 587K | 594K |
| Stock-Based Compensation | 0 | 1.59M | 1.63M | 1.55M | 2.05M | 2.18M | 1.91M | 1.48M | 1.41M | 1.39M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.39M | 9.74M | -4.51M | -509K | -723K | -1.04M | 318K | 2.08M | -100K | 424K |
| Working Capital Changes | 506K | -6.38M | 4.9M | -3.41M | -1.49M | -311K | 3.01M | -7K | -3.02M | -1.09M |
| Change in Receivables | 67K | 28K | -116K | 204K | -88K | 555K | 760K | 262K | 35K | 1.72M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.81M | -150K | -442K | -209K | 41K | -82K | 704K | -954K | 851K | -1.92M |
| Cash from Investing | 15.32M | 16.04M | 16.28M | 21.12M | 9.97M | -966K | -130.63M | 1.35M | 9.78M | -2.67M |
| Capital Expenditures | -242K | -421K | -600K | -1.05M | -511K | -64K | -96K | -464K | -18K | -636K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | 7.17% | 27.06% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -112K | -121K | -37K | -72K | 239K | -30K | 163.87M | -1.62M | 0 | 962K |
| Debt Issued (Net) | -33K | 0 | 0 | -33K | -33K | -33K | -38K | -78K | 0 | 0 |
| Equity Issued (Net) | 131K | 0 | 0 | 0 | 0 | -4.18M | 166.51M | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -4.18M | 166.51M | 0 | 0 | 0 |
| Other Financing | -210K | -121K | -37K | -39K | 272K | 4.19M | -2.6M | -1.54M | 0 | 962K |
| Net Change in Cash | -5.75M | 1.19M | -2.96M | -1.93M | -9.63M | -15.65M | 21.63M | -13.95M | -5.3M | -12.38M |
| Free Cash Flow | -21.19M | -15.15M | -19.8M | -24.04M | -20.35M | -14.71M | -11.71M | -14.15M | -15.1M | -11.31M |
| FCF Margin % | - | - | - | - | - | - | - | - | -6017.53% | -481.32% |
| FCF Growth % | -4.13% | -2.94% | -69.14% | -69.89% | -34.75% | -30.09% | - | - | - | - |
| FCF per Share | -0.86 | -0.62 | -0.81 | -0.99 | -0.84 | -0.60 | -0.48 | -0.61 | -0.86 | -0.55 |
| FCF Conversion (FCF/Net Income) | 0.89x | 0.71x | 0.89x | 1.08x | 0.98x | 1.59x | 0.66x | 0.77x | 1.08x | 0.89x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |